Captopril-induced Cough: Does it Matter in Children? A Retrospective Cohort Study

References

1. Ritter J. Rang and Dale’s Pharmacology. Edinburgh Elsevier 2020
   [Google Scholar]
2. Whittlesea C. Hodson K. Clinical Pharmacy and therapeutics. 6th ed Oxford Elsevier 2019 361 364
   [Google Scholar]
3. Brunton L.L. Knollmann B.C. 14th ed New York McGraw Hill 2023 588 590 597-600
   [Google Scholar]
4. Vanderah T.W. 16th ed New York McGraw Hill 2024 316 7
   [Google Scholar]
5. Stoller J.K. Elghazawi A. Mehta A.C. Vidt D.G. Captopril-induced Cough. Chest 1988 93 3 659 661 10.1378/chest.93.3.659 3277811
   [Google Scholar]
6. Yilmaz I. Angiotensin-converting enzyme inhibitors induce cough. Turk. Thorac. J. 2019 20 1 36 42 10.5152/TurkThoracJ.2018.18014 30664425
   [Google Scholar]
7. Dicpinigaitis P.V. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006 129 1 169S 173S (Suppl.) 10.1378/chest.129.1_suppl.169S 16428706
   [Google Scholar]
8. Irwin R.S. French C.L. Chang A.B. Classification of cough as a symptom in adults and management algorithms. Chest 2018 153 1 196 209 10.1016/j.chest.2017.10.016 29080708
   [Google Scholar]
9. Loo H.C. Osman F. Ho S.L. An S.Y. Au Yong Y.M. Khoo E.M. Incidence of angiotensin-converting enzyme inhibitor-induced cough in a Malaysian public primary care clinic: A retrospective cohort study. Malays. Fam. Physician 2022 17 1 66 70 10.51866/oa.80 35440970
   [Google Scholar]
10. Pinto B. Jadhav U. Singhai P. Sadhanandham S. Shah N. ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction. Indian Heart J. 2020 72 5 345 350 10.1016/j.ihj.2020.08.007 33189192
    [Google Scholar]
11. Izzo J.L. Weir M.R. Angiotensin-converting enzyme inhibitors. J. Clin. Hypertens. 2011 13 9 667 675 10.1111/j.1751‑7176.2011.00508.x 21896148
    [Google Scholar]
12. Momma K. ACE inhibitors in pediatric patients with heart failure. Paediatr. Drugs 2006 8 1 55 69 10.2165/00148581‑200608010‑00005 16494512
    [Google Scholar]
13. Grenier M.A. Fioravanti J. Truesdell S.C. Mendelsohn A.M. Vermilion R.P. Lipshultz S.E. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: A review. Prog. Pediatr. Cardiol. 2000 12 1 91 111 10.1016/S1058‑9813(00)00061‑8 11114549
    [Google Scholar]
14. Saheb Sharif-Askari N. Airways expression of SARS-COV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol. Ther. Methods Clin. Dev. 2020 18 1 6 10.1016/j.omtm.2020.05.013 32537478
    [Google Scholar]
15. Silva M.G. Falcoff N.L. Corradi G.R. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels. Pediatr. Res. 2023 93 4 948 952 10.1038/s41390‑022‑02163‑z 35739259
    [Google Scholar]